Stocks to watch: Wipro, Cadila Healthcare, NCL Industries


Zydus Cadila Receives Final Green Light From USFDA For Vortioxetine Tablets, Used To Treat Depression

Domestic stock markets are expected to open in the red due to negative global indices. U.S. stocks ended sharply lower on Friday, ending a week shaken by strong economic data, concerns over corporate tax hikes, the Delta COVID variant and possible changes to the Reserve’s schedule federal government for reducing asset purchases. Asian stocks eased Monday before a week marked by no less than a dozen central bank meetings, highlighted by the Federal Reserve which is expected to take a further step towards reduction. And the trends on SGX Nifty indicate a downward opening for the Nifty, with a loss of 129 points.

ALSO READ  A Free-Crypto project scanned the eyeballs of 130,000 people

On Friday, BSE Sensex corrected 125.27 points to close at 59,015.89 and Nifty fell 44.30 points to 17,585.20.

Actions to watch for in today’s session


Wipro launched the Wipro-Google Cloud Innovation Arena in Bangalore, Wipro said in a regulatory filing filed with the exchanges.

Cadila Health

Zydus Cadila has received final approval from the USFDA for vortioxetine tablets, which are used to treat depression.

ALSO READ  Tata Sons to acquire Air India for Rs 18,000 crore

NCL Industries

NCL Industries has entered into a joint venture agreement with Moravia Containers AS of the Czech Republic to create a joint venture for the manufacture of containers and modular systems.

Nazara Technologies

NODWIN Gaming, an independent subsidiary of Nazara Technologies, acquired the games and adjacent intellectual property business of OML Entertainment for Rs 73 crore.